Last kr21.20 SEK
Change Today +0.20 / 0.95%
Volume 3.5K
As of 7:26 AM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for oasmia pharmaceutical ab (OASM)

Year over year, Oasmia Pharmaceutical AB (publ) has seen revenues fall from kr48.6M SEK to kr29.5M SEK. This along with an increase in SGA costs has led to a reduction in the bottom line from a loss of kr72.4M SEK to an even larger loss of kr105.1M SEK.
View Income Statement In U.S. Dollar
Currency in
Millions of Swedish Kronas
As of:Apr 30
2011
Reclassified
SEK
Apr 30
2012
SEK
Apr 30
2013
SEK
Apr 30
2014
Press
Release

SEK
4 Year
Trend
Revenues86.264.248.629.5
Other Revenues0.20.10.2--
TOTAL REVENUES86.464.348.829.5
Cost of Goods Sold16.110.16.16.8
GROSS PROFIT70.354.242.722.7
Selling General & Admin Expenses, Total129.8114.6107.4120.3
Depreciation & Amortization, Total4.75.15.14.9
Other Operating Expenses-------0.2
OTHER OPERATING EXPENSES, TOTAL134.5119.7112.5125.0
OPERATING INCOME-64.2-65.5-69.8-102.3
Interest Expense-2.1-0.5-5.3-7.2
Interest and Investment Income0.50.30.60.2
NET INTEREST EXPENSE-1.6-0.2-4.7-7.0
Currency Exchange Gains (Loss)0.00.0-0.1--
Other Non-Operating Income (Expenses)0.00.00.0--
EBT, EXCLUDING UNUSUAL ITEMS-65.9-65.7-74.6-109.4
Gain (Loss) on Sale of Assets-0.1--1.5--
Other Unusual Items, Total0.0--0.84.3
Insurance Settlements----0.84.3
Other Unusual Items0.0------
EBT, INCLUDING UNUSUAL ITEMS-66.0-65.7-72.4-105.1
Income Tax Expense0.0------
Earnings from Continuing Operations-66.0-65.7-72.4-105.1
NET INCOME-66.0-65.7-72.4-105.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-66.0-65.7-72.4-105.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-66.0-65.7-72.4-105.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OASM:SS kr21.20 SEK +0.20

OASM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OASM.
View Industry Companies
 

Industry Analysis

OASM

Industry Average

Valuation OASM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 56.9x
Price/Book 6.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 53.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OASMIA PHARMACEUTICAL AB, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.